BAILLIE GIFFORD & CO - 31 Dec 2024 SCHEDULE 13G/A Report for RECURSION PHARMACEUTICALS, INC. Common Stock (DNA)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: RECURSION PHARMACEUTICALS, INC. Common Stock
Symbol: DNA
Shares outstanding: 382,523,969 shares
Disclosed Ownership: 24,864,058 shares
Ownership: 6.5%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 09:32:34 UTC
Date of event: 31 Dec 2024
Previous filing: 04 Nov 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	6.5%	24,864,058	24,786,819	0	Grant Meikle	Threshold & Transaction Reporting Manager